Galderma Group N EBIT for the year ending December 31, 2024: USD 666.00 M

Galderma Group N EBIT is USD 666.00 M for the year ending December 31, 2024, a 9.69% change year over year. EBIT means earnings before interest and taxes, it is calculated as operating income plus non-operating income.
  • Galderma Group N EBIT for the year ending December 31, 2023 was USD 607.18 M, a 71.70% change year over year.
  • Galderma Group N EBIT for the year ending December 31, 2022 was USD 353.63 M, a 30.12% change year over year.
  • Galderma Group N EBIT for the year ending December 31, 2021 was USD 271.78 M.
Key Data
Date EBIT EBITDA Net Income EPS (Diluted)